The immune response to a polyoma virus replicon-based DNA vaccine

Citation
A. Mena et al., The immune response to a polyoma virus replicon-based DNA vaccine, VACCINE, 19(1), 2000, pp. 68-74
Citations number
28
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Issue
1
Year of publication
2000
Pages
68 - 74
Database
ISI
SICI code
0264-410X(20000815)19:1<68:TIRTAP>2.0.ZU;2-G
Abstract
DNA vaccination has proven to be effective against a number of tumours and microbial diseases. As DNA vaccines are unable to replicate, plasmid copy n umber per cell is dependent on in vivo transfection efficiency, which is us ually quite low. Consequently, immune responses generated are likely to be sub-optimal due to low antigen expression levels in transfected cells. Duri ng this study, replicating: DNA vaccines delivered intra-epidermally by gen e gun, were assessed for their ability to more efficiently generate immune responses in mice. The data demonstrate that, using a polyoma virus-based s ystem of replication, 10-fold less DNA expressing the haemagglutinin gene o f influenza virus, was required to stimulate a humoral immune response, com pared to an equivalent non-replicating vaccine. This observation suggests t hat the use of replicating DNA vaccines in some delivery systems may enhanc e the effectiveness of immune responses. (C) 2000 Elsevier Science Ltd. All rights reserved.